Company: BLRX
Filing Date: 2025-01-07
Form Type: 424B5
Source: 0001178913-25-000045
Chunk: 89

Company: BioLineRx Ltd.
Filing Date: 2025-01-07
Form: 424B5
Chunk 89
---
 through dealers, who may act as agents or principals, including a block trade (which may involve crosses) in which a broker or dealer so engaged will attempt to sell as agent but may position and 
 resell a portion of the block as principal to facilitate the transaction;                                                                                                                                 |

| ● | through privately negotiated transactions; |

| ● | purchases by a broker or dealer as principal and resale by such broker or dealer for its own account pursuant to this prospectus; |

| ● | directly to purchasers, including our affiliates, through a specific bidding or auction process, on a negotiated basis or otherwise; to or through one or more underwriters on a firm commitment or best 
 efforts basis;                                                                                                                                                                                           |

| ● | exchange distributions and/or secondary distributions; |

| ● | ordinary brokerage transactions and transactions in which the broker solicits purchasers; |

| ● | in “at-the-market” offerings, within the meaning of Rule 415(a)(4) of the Securities Act to or through a market maker or into an existing trading market, on an exchange or otherwise; |

| ● | transactions not involving market makers or established trading markets, including direct sales or privately negotiated transactions; |

| ● | transactions in options, swaps or other derivatives that may or may not be listed on an exchange or |

| ● | through any other method permitted pursuant to applicable law; or |

| ● | through a combination of any such methods of sale. |

At any time a particular offer of the securities covered by this prospectus is made, a revised prospectus or prospectus supplement, if required, will be distributed which will set forth the aggregate amount of securities covered by this prospectus being offered and the terms of the offering, including the name or names of any underwriters, dealers, brokers or agents, any discounts, commissions, concessions and other items constituting compensation from us and any discounts, commissions or concessions allowed or re-allowed or paid to dealers. Such prospectus supplement, and, if necessary, a post-effective amendment to the registration statement of which this prospectus is a part, will be filed with the SEC to reflect the disclosure of additional information with respect to the distribution of the securities covered by this prospectus. In order to comply with the securities laws of certain states, if applicable, the securities sold under this prospectus may only be sold through registered or licensed broker-dealers. In addition, in some states the securities may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from registration or qualification requirements